Prot #XTMAB‐16‐201: A Seamless, Phase 1b/2 Multiple Ascending Dose/Proof of Concept Study of XTMAB‐16 in Patients with Pulmonary Sarcoidosis with or without Extrapulmonary Manifestations

Sporn, Peter H (PD/PI)

Medicine, Pulmonary Division

Project: Research project

Status	Active
Effective start/end date	9/13/23 → 9/13/26

Funding

Pharmaceutical Research Associates, Inc. (Prot #XTMAB-16-201 AMD 1 // Prot #XTMAB-16-201 AMD 1)
Xentria, Inc. (Prot #XTMAB-16-201 AMD 1 // Prot #XTMAB-16-201 AMD 1)